Jonathan P. Mow - Nov 3, 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
Chief Executive Officer, Director
Signature
/s/ John P. Sharp, Attorney-in-fact
Stock symbol
PHASQ
Transactions as of
Nov 3, 2021
Transactions value $
$0
Form type
4
Date filed
11/3/2021, 07:30 PM
Previous filing
Aug 30, 2021
Next filing
Nov 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Options Exercise $24.8K +20K +13.62% $1.24* 167K Nov 3, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Employee Stock Option (right to buy) Options Exercise -$24.8K -20K -15.53% $1.24* 109K Nov 3, 2021 Common Stock 20K $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares underlying this option have vested.